National Research CORP 10-Q quarterly reports

NRC Health filed its Form 10-Q for the quarter ended June 30, 2026, reporting a net loss of $3.3 million on increased revenue, with significant rises in operating expenses driven by stock-based compensation.

NRC Health reported a 4% increase in Q1 2026 revenue to $34.8 million, but operating income fell 35% to $5.6 million due to increased expenses.

NRC Health reports a decline in Q3 2025 revenue and net income, while appointing Shane Harrison as its new CFO and increasing Total Recurring Contract Value.

National Research Corporation reported a significant decline in second-quarter net income and revenue, impacted by substantial executive compensation expenses, despite sequential improvements in recurring contract value.

National Research Corporation (NRC Health) announces its Q1 2025 financial results, including a decrease in revenue and the appointment of Trent Green as the new CEO effective June 1, 2025.

National Research Corporation's Q3 2024 results show a decrease in revenue compared to the same period last year, alongside increased investments in strategic initiatives and a recent acquisition.

National Research Corporation's second quarter 2024 results show a revenue decrease compared to the same period last year, alongside a strategic acquisition of Nobl, Inc.

National Research Corporation's first quarter 2024 results show a decrease in revenue compared to the same period last year, alongside strategic adjustments in operations and investments.